Advertisement
ProteinSimple
ProteinSimple

The Scientist

» monoclonal antibodies

Most Recent

image: In Situ Antibodies

In Situ Antibodies

By | February 2, 2016

Compared with systemic injections, localized antibody therapies may be more effective for some indications.

2 Comments

image: Antibody Alternatives

Antibody Alternatives

By and | February 1, 2016

Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

1 Comment

image: Exercises for Your Abs

Exercises for Your Abs

By | February 1, 2016

Companies make the antibodies, but it’s up to you to make sure they work in your experiments.

1 Comment

image: Building Better Reagents

Building Better Reagents

By and | February 1, 2016

Facing problems of inconsistent, time-consuming, and costly antibody production, some researchers are turning to alternatives to target specific proteins of interest, in the lab and in the clinic.

0 Comments

Some antibodies designed to eliminate the plaques prominent in Alzheimer’s disease can aggravate neuronal hyperactivity in mice.

1 Comment

image: Two-Faced Proteins May Tackle HIV Reservoirs

Two-Faced Proteins May Tackle HIV Reservoirs

By | October 21, 2015

Researchers design antibody-like proteins to awaken and destroy HIV holdouts.

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

image: Moving MERS Therapies Forward

Moving MERS Therapies Forward

By | July 28, 2015

Scientists wonder whether they can obtain the resources to test experimental vaccines and treatments in humans.

3 Comments

image: MERS Research Outpaced by Outbreaks

MERS Research Outpaced by Outbreaks

By | June 18, 2015

Questions about the transmission and pathogenesis of Middle East respiratory syndrome remain as the coronavirus spreads.

1 Comment

image: Funds To Speed Ebola Drug Development

Funds To Speed Ebola Drug Development

By | September 4, 2014

A $42 million US government contract awarded to an experimental Ebola medicine maker aims to accelerate the process of meeting demand for the therapeutic.

0 Comments

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Advertisement
Life Technologies